COVID-19 Vaccine: Trials of the first part of the first phase of Covaxin, the first indigenous potential COVID-19 Vaccine, have been completed. The results are encouraging. This was told by news agency ANI, Principal Investigator of the Vaccine Trial Team at Post Graduate Institute (PGI) of Medical Sciences, Rohtak.
The Human Trials of Covaxin started at PGI Rohtak on 17 July. In the first part of the first phase of the trials, 50 people were vaccinated. On Saturday, 6 people were vaccinated under the second part of its first phase trial.
Bharat Biotech has created
Covaxin has been developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV). Clinical trials of the first and second stages of this vaccine candidate have been approved. It will be manufactured at the company’s Hyderabad factory.
Trial has already started in Delhi AIIMS
Human trials of the first phase of ‘Covaxin’ started in Delhi AIIMS on Friday. The first dose of this vaccine was given to a 30-year-old man. According to Dr. Sanjay Rai, Professor of Center for Community Medicine, AIIMS, more than 3500 people have registered for the vaccine trial in AIIMS. At least 22 of these people are being screened. The first volunteer is a resident of Delhi and is completely healthy, all his health parameters are correct. He does not have any disease. So far no side effects have been shown on it.
Trial in 12 institutes
The Indian Council of Medical Research (ICMR) has selected 12 institutes, including Delhi-based AIIMS, for the first and second phase trials on Kovaxin humans. In the first phase, the vaccine will be tested on 375 people. There will be a trial on 750 people in the second phase.
Financial & Business News – CapitalBoat
CapitalBoat provides the latest stock market, financial and business news. Get stock market quotes, personal financial advice, corporate news, Startup stories and latest updates on Economy & Politics, Personal Finance on your Whats app.
Get Breaking News Notifications Via Whats app.
Join our whats app newsletter using this invite link. Click on the link to open chat and send message ‘START’ to join us.
Please forward this message on to your Friends, Colleagues and Family members who may be interested in this.